- Synonyms
 
							- IL-1RN, IRAP
 
						
						
						
						
											
											
											
										
										
					
					
											
							
- Source
 
							- Escherichia coli.
 
						
																
							
- Molecular Weight
 
							- Approximately 17.1 kDa, a single non-glycosylated polypeptide chain containing 152 amino acids.
 
						
					                    
                                        
                  
                    
                    
                    
                    
											
							
- AA Sequence
 
							- RPSGRKSSKM QAFRIWDVNQ KTFYLRNNQL VAGYLQGPNV NLEEKIDVVP IEPHALFLGI HGGKMCLSCV KSGDETRLQL EAVNITDLSE NRKQDKRFAF IRSDSGPTTS FESAACPGWF LCTAMEADQP VSLTNMPDEG VMVTKFYFQE DE
 
						
											
							
- Purity
 
							- > 96 % by SDS-PAGE and HPLC analyses.
 
						
											
							
- Biological Activity
 
							- Fully biologically active when compared to standard. The ED50 as determined by inhibiting IL-1α-dependent proliferation of murine D10S cells is less than 40 ng/ml, corresponding to a specific activity of > 2.5 × 104 IU/mg in the presence of 50 pg/ml rHuIL-1α.
 
						
											
							
- Physical Appearance
 
							- Sterile Filtered White lyophilized (freeze-dried) powder.
 
						
											
							
- Formulation
 
							- Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4.
 
						
											
							
- Endotoxin
 
							- Less than 1 EU/µg of rHuIL-1RA as determined by LAL method.
 
						
											
							
- Reconstitution
 
							- We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
 
						
											
							
- Stability & Storage
 
							- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 3 months, -20 to -70 °C under sterile conditions after reconstitution. 
						
											
							
- Usage
 
							- This material is offered by Shanghai PrimeGene Bio-Tech for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE.
 
						
					                    
					                    
                                         
                                        
                                        
                                        
                                        
                                        
                   
											
							- SDS-PAGE
 
							
 
						 
										
					
					
											
							
- Reference
 
							- 1.	Dinarello, C.A. 1994. FASEB J, 8: 1314-25.
2.	Perrier, S., F. Darakhshan, and E. Hajduch. 2006. FEBS Lett, 580: 6289-94.
3.	Dinarello, C.A. 1994. FASEB J, 8: 1314-25. 
						
										
											
							
- Background
 
							- Interleukin-1 receptor antagonist (IL-1RA) is a member of the IL-1 family. IL1RA is secreted by various types of cells including immune cells, epithelial cells, and adipocytes, and is a natural inhibitor of the pro-inflammatory effect of IL1β. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses. IL-4 and IL-13 have been shown to amplify the stimulatory effect of IL1-beta on the production of soluble and intracellular forms of IL1-RA. The regulated expression of IL1RA in various cell types has been shown to be influenced by cytokines. In synovial fibroblasts the synthesis of IL-1RA is markedly enhanced by IL-1, TNF-alpha, or PDGF. The protein shows 26 % amino acid homology to IL1β and 19 % homology to IL1α.